Results 1 to 10 of about 5,489,565 (248)

Encapsulation of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in liposomes prepared by thin film hydration and their transfer to mesenchymal stem cells and cord blood hematopoietic stem cells

open access: yesArchives of Medical Science, 2020
Introduction Cytokines are important immune modulator factors controlling homeostasis of the body and are involved in tissue regeneration after wound healing.
Sławomir Lewicki   +8 more
doaj   +2 more sources

The effects of granulocyte-colony stimulating factor on chronic liver disease: a meta-analysis

open access: yesJournal of Infection in Developing Countries, 2022
Introduction: The clinical application of granulocyte-colony stimulating factor on chronic liver disease is still controversial. The study aimed to evaluate the effects of granulocyte-colony stimulating factor on chronic liver disease. Methodology: A
Pei Shi   +6 more
doaj   +1 more source

Granulocyte colony‐stimulating factor associated arteritis in a patient with castration‐resistant prostate cancer

open access: yesIJU Case Reports, 2022
Introduction Granulocyte colony‐stimulating factor‐associated arteritis is a rare adverse event of granulocyte colony‐stimulating factor, with an incidence of 0.47% among all patients who receive granulocyte colony‐stimulating factor. We herein present a
Satoshi Nitta   +9 more
doaj   +1 more source

Outcome and Cost-Effectiveness Analysis of Long-acting G-CSF as Primary Prophylaxis of Neutropenia Induced by Chemotherapy in Breast Cancer Patients, From a Retrospective Study

open access: yesCancer Control, 2023
Purpose This retrospective analysis aimed to evaluate the clinical outcomes and cost-effectiveness of long-acting granulocyte-colony stimulating factor as primary prophylaxis of neutropenia caused by chemotherapy for breast cancer.
Yaqin Wang PhD   +3 more
doaj   +1 more source

Favorable response to pembrolizumab in granulocyte colony‐stimulating factor‐producing upper urinary tract urothelial carcinoma

open access: yesIJU Case Reports, 2022
Introduction Granulocyte colony‐stimulating factor‐producing upper urinary tract urothelial carcinoma is rare, with a poor prognosis. Advanced urothelial carcinoma is currently treated with immune checkpoint inhibitors, whose efficacy for granulocyte ...
Hiroki Takeda   +9 more
doaj   +1 more source

Granulocyte colony‐stimulating factor producing retroperitoneal leiomyosarcoma

open access: yesIJU Case Reports, 2021
Introduction Granulocyte colony‐stimulating factor‐producing nonhematopoietic malignancies have poor clinical outcomes. Case presentation A 62‐year‐old woman complaining of fever and left lower quadrant pain was referred to our hospital.
Kyotaro Fukuta   +9 more
doaj   +1 more source

Transient thrombocytopenia in a cat following G‐CSF treatment

open access: yesVeterinary Medicine and Science, 2022
A 4‐year‐old, castrated male, Russian blue cat with idiopathic epilepsy was diagnosed with neutropenia. The neutropenia was classified as idiopathic after blood tests and abdominal imaging did not reveal an infectious, inflammatory or neoplastic ...
Kyeong‐Bo Kim   +6 more
doaj   +1 more source

Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: a case report

open access: yesJournal of Medical Case Reports, 2008
Introduction The granulocyte-colony stimulating factor-producing tumor was first reported in 1977, however, anaplastic pleomorphic type carcinoma of the pancreas producing granulocyte-colony stimulating factor is still rare.
Nakajima Atsushi   +6 more
doaj   +1 more source

Dexamethasone and granulocyte colony-stimulating factor alter the representation of cellular patterns and neurotisation of regenerative neuroma

open access: yesPatologìâ, 2023
Aim. To evaluate the changes in the total cellularity (Nuc) of the rat sciatic nerve regenerative neuroma (RegN) and its representation of CD90, CD44, CD146, and CD133 positive cells, as well as its neurotization under the conditions of dexamethasone ...
O. M. Grabovyi   +4 more
doaj   +1 more source

Granulocyte-macrophage colony-stimulating factor increases tumor growth and angiogenesis directly by promoting endothelial cell function and indirectly by enhancing the mobilization and recruitment of proangiogenic granulocytes

open access: yesTumor Biology, 2017
Granulocyte-macrophage colony-stimulating factor has been widely used as an adjuvant therapy for cancer patients exhibiting myelosuppression induced by chemotherapy or radiotherapy. However, the effects of granulocyte-macrophage colony-stimulating factor
Qiaowei Zheng   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy